Kilitch Drugs (India) Ltd - KILITCH DRUGS Share Price

Sector: Pharmaceuticals | ISIN: INE729D01010
₹ 419.90 (0.04%) icon27 Feb, 2024, 12:00:00 AM
Open
₹ 425.95
Prev. Close
₹ 419.75
Turnover(lac)
₹ 0.00
Day's High
₹ 429.95
Day's Low
₹ 408.20
52 Wk High
₹ 470.00
52 Wk Low
₹ 125.00
Book Value
₹ 132.89
Face Value
₹ 10.00
Mkt. Cap (Cr.)
₹ 675.30
P/E
35.73
EPS
11.85
Div. Yield
0.00

Kilitch Drugs (India) Ltd Stock View

info icon
Edit Image
Target | 02 Nov, 2023 393 (-6.37%)

Kilitch Drugs (India) Limited is an India-based pharmaceutical manufacturing company. The Company is engaged in developing, manufacturing and marketing a range of pharmaceutical formulations... Read More

Kilitch Drugs (India) Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/27/2024 12:00:00 AM

    ₹ 419.9 0.15 0.04
  • Open
  • ₹ 425.95
  • Prev. Close
  • ₹ 419.75
  • Turnover(Lac.)
  • ₹ 58
  • Day's High
  • ₹ 429.95
  • Day's Low
  • ₹ 408.2
  • 52 Week's High
  • ₹ 470
  • 52 Week's Low
  • ₹ 125
  • Book Value
  • ₹ 132.89
  • Face Value
  • ₹ 10
  • Mkt Cap (₹ Cr.)
  • 675.3
  • P/E
  • 35.73
  • EPS
  • 11.85
  • Divi. Yield
  • 0

Kilitch Drugs (India) Ltd Corporate Actions

31 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jan , 2024

12:00 AM

01 Nov , 2023

12:00 AM

01 Nov , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

11 Aug , 2023

12:00 AM

AGM

Announcement date: 11 Aug , 2023

View Details

04 Aug , 2023

12:00 AM

04 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

29 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

19 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 May , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

15 Mar , 2023

12:00 AM

15 Mar , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

14 Aug , 2023

12:00 AM

BookCloser

View Details

Kilitch Drugs (India) Ltd News and Update

Image not found
  • 4 hours ago |
  • 12:13 AM

Nippon India and Tata Mutual implemented certain limitations on investments made in their small-cap programs in 2023.

Image not found
  • IIFL News Service |
  • 6 hours ago |
  • 12:13 AM
Image not found
  • IIFL News Service |
  • 6 hours ago |
  • 12:13 AM
Image not found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Kilitch Drugs (India) Ltd SHAREHOLDING SNAPSHOT
27 February , 2024 | 06:02 PM

PROMOTER - TOTAL69.23%

Indian: 69.23%

Foreign: 0%

NON-PROMOTER - TOTAL 30.77%

Institutions: 0.00%

Non-Institutions: 30.77%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Kilitch Drugs (India) Ltd FINANCIALS

Kilitch Drugs (India) Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Kilitch Drugs (India) Ltd

  • Mukund P Mehta
  • Managing Director
  • Bhavin M Mehta
  • Whole-time Director
  • Hemang Engineer
  • Independent Director
  • Mira Bhavin Mehta
  • Whole-time Director
  • Murti Vasudev Krishna
  • Independent Director
  • Venkita Subramanian Rajan
  • Independent Director
  • Pushpa Nyoupane
  • Company Sec. & Compli. Officer

Summary

Kilitch Drugs (India) Limited (KDIL) was incorporated in May, 1992 as a public limited company. The Company is a pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets, capsules,liquid orals, ointments, creams and injectables. Even before the plant was commissioned, the company came out with a rights issue in Oct.95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sanaa Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies, south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit, which was... Read More


Reports by Kilitch Drugs (India) Ltd


Reports by Kilitch Drugs (India) Ltd

Company FAQ

No Record Found